Form 8-K - Current report:
SEC Accession No. 0001477932-25-005090
Filing Date
2025-07-16
Accepted
2025-07-16 17:00:17
Documents
17
Period of Report
2025-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 35044
2 FORM OF SECURITIES PURCHASE AGREEMENT upxi_ex101.htm EX-10.1 258988
3 PLACEMENT AGENCY AGREEMENT upxi_ex102.htm EX-10.2 41234
4 FORM OF REGISTRATION RIGHTS AGREEMENT upxi_ex103.htm EX-10.3 129975
  Complete submission text file 0001477932-25-005090.txt   687282

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA upxi-20250711.xsd EX-101.SCH 5024
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20250711_lab.xml EX-101.LAB 14667
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20250711_cal.xml EX-101.CAL 898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20250711_pre.xml EX-101.PRE 9275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20250711_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 3884
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 251127979
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)